Skip to main content

Advanz Pharma Corporation Ltd. (CXRXF)

Jun 11, 2021 - CXRXF was delisted (reason: acquired by Nordic Capital)
17.06 0.00 (0.00%)
Jun 10, 2021 9:30 AM EDT - Market closed
Market Cap834.46M
Revenue (ttm)531.70M
Net Income (ttm)n/a
Shares Out48.91M
EPS (ttm)-1.66
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume0
Open17.06
Previous Close17.06
Day's Range17.06 - 17.06
52-Week Range2.13 - 17.50
Beta-0.29
Analystsn/a
Price Targetn/a
Est. Earnings DateAug 11, 2021

About CXRXF

ADVANZ PHARMA Corp. Limited, a pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products worldwide. The company operates through two segments: ADVANZ PHARMA International and ADVANZ PHARMA North America. Its ADVANZ PHARMA International segment offers a portfolio of branded and generic prescription products to wholesalers, distributors, hospitals, and pharmacies. This segment's products include Brinavess for the conversion of onset atrial fibrillation to sinus rhythm in adults; Ag...

IndustryPharmaceuticals
CEOGraeme Neville Duncan
CountryUnited Kingdom
Stock ExchangeOTCMKTS
Ticker SymbolCXRXF
Full Company Profile

News

There is no news available yet.